Skip to main content

Table 3 Proportion of patients on statin medication in each study group over time; n = 513

From: Successful implementation of best medical treatment for patients with asymptomatic carotid artery stenosis within a randomized controlled trial (SPACE-2)

Visit

CEA

CAS

BMT

total

p1

p2

Screening□

80.3% (163)

73.6% (145)

78.8% (89)

77.4% (397)

0.257⌐

 

D30

87.6% (163)

86.7% (156)

91.5% (97)

88.1% (416)

0.456⌐

 < 0.0001^*

M6

91.7% (166)

86.9% (152)

93.5% (101)

90.3% (419)

0.131⌐

 < 0.0001^*

A1

92.5% (160)

87.6% (149)

93.2% (96)

90.8% (405)

0.190⌐

 < 0.0001^*

  1. *Significant
  2. ⌐Chi2-test
  3. ^McNemar test
  4. □Already published [23]; D30: Visit 30 days after screening visit; M6: Visit 6 months after screening visit; A1: Visit o ne year after screening visit
  5. 1testing CEA vs. CAS vs. BMT
  6. 2testing rate of statin medication on D30/M6/A1 vs. screening visit
Back to article page

Neurological Research and Practice

ISSN: 2524-3489

Contact us